Clinical trial NCT05266755: Hospital Readmission After HIPr Fracture. Impact of a Territorial Fracture Liason Service
Official title: Hospital Readmission After HIPr Fracture. Impact of a Territorial Fracture Liason Service
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Hip Fractures
Lead sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Sponsor class: OTHER
First posted: 2022-03-04
Enrollment: 120
Sex: ALL
Minimum age (years): 65
Maximum age (years): 99
Standard ages: OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Multicenter clinical trial. Adult patients who consult the Hospital Emergency Department (ED) of the Hospital de la Santa Creu i Sant Pau (HSCSP) for an FxF PSM as a primary or secondary diagnosis will be selected and will be randomized with a 1:1 distribution to be included in the FLS -CTSPau (intervention group) or to receive usual care (control group). The result of the intervention will be evaluated in terms of health outcomes (re-consultations, hospital readmissions and quality of life).
Primary purpose: TREATMENT

Brief summary: The International Osteoporosis Foundation (IOF) and the American Society for Bone Research and Mineral Metabolism recommend the creation and implementation of fracture coordination services (FLS) as the most efficient way to address the problem. FLS has emerged as a new clinical approach that uses coordinated, multidisciplinary care to improve post-fracture outcomes and reduce recurrent fractures. It is a multidisciplinary and protocolized care model that must guarantee:

1. Identify fragility fractures and people at risk for a fracture
2. Fracture risk assessment
3. Indication for treatment or referral
4. Improvement in therapeutic compliance
5. Reduce the risk of falls It is known that patients who have undergone a FLS model (vs no FLS), have lower mortality, lower risk of fracture, with a reduction of 35% and 56%, respectively, during two years of follow-up. One of the most important objectives of the FLS is the proper recognition and treatment of osteoporosis (OP) in patients with fragility fractures. A major problem is the lack of adherence to treatment for OP, and inclusion in an FLS program increases the prescription of bisphosphonates from 17.9% to 76%. In addition, a specific follow-up program means that 73% of patients followed by FLS continue to undergo anti-resorptive treatment after 2 years of having suffered a femur fracture.

Detailed description: Hypothesis After a femur fracture due to fragility, upon discharge from surgery at the Hospital de la Santa Creu i Sant Pau, including patients in a regional FLS program will make it possible to complete the study of the patient with fracture, improve adherence to treatment of OP (secondary prevention), and obtain better functional recovery.

Eligibility criteria: Inclusion Criteria:

* All hip fractures older than 65 years

Exclusion Criteria:

* Politraumatic fractures
* Metastasic fractures

Primary outcomes:
measure: Number of Deaths
timeFrame: 1 year after discharge
measure: Number of Falls
timeFrame: 1 year after discharge
measure: Percentage of patients with adequated Osteoporotic treatment
timeFrame: 1 year after discharge
Secondary outcomes:
measure: Barthel at the end of follow up
timeFrame: 1 year after discharge
Other outcomes:
Locations:
city: Barcelona
country: Spain
facility: Jordi Martin Marcuello
state: Catalunya
Study officials:
References: